Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology

Parse Biosciences and Nomic Bio have partnered to create Cascade, a massive, licensable dataset designed to map the human immune response at an unprecedented scale. By integrating single-cell transcriptomics with proteomic secretome data, this resource captures how immune cells react to thousands of drug and cytokine perturbations over time. This multimodal approach provides deep cellular and protein-level insights that are critical for understanding complex immune signaling mechanisms. The initiative directly addresses a significant data bottleneck in biological AI modeling. Current predictive models for drug discovery lack sufficient high-quality data to accurately simulate how immune systems respond to new treatments. By providing an AI-ready resource of this magnitude, Cascade enables researchers to build more accurate virtual cell models, thereby improving the efficiency of identifying and validating novel therapeutic targets in pharmaceutical development. This release is highly relevant to open data initiatives because it highlights the growing necessity for large-scale, standardized, and accessible biological datasets. While the data is commercially licensed, its creation underscores a broader shift toward making complex, multimodal omics data available to the scientific community. Such resources are essential for advancing open science in bioinformatics, allowing for greater collaboration, reproducibility, and innovation in understanding human health and disease.

Source: nugget.ca
Published on 2026-10-30

Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology

Related news